BACKGROUND: The study of disparities in minority recruitment to cancer clinical trials has focused primarily on inquiries among minority populations. Yet very little is known about the perceptions of individuals actively involved in minority recruitment to clinical trials within cancer centers. Therefore, the authors assessed the perspectives of cancer center clinical and research personnel on barriers and facilitators to minority recruitment. METHODS: In total, 91 qualitative interviews were conducted at 5 US cancer centers among 4 stakeholder groups: cancer center leaders, principal investigators, research staff, and referring clinicians. All interviews were recorded and transcribed. Qualitative analyses of response data was focused on identifying prominent themes related to barriers and facilitators to minority recruitment. RESULTS: The perspectives of the 4 stakeholder groups were largely overlapping with some variations based on their unique roles in minority recruitment. Four prominent themes were identified: 1) racial and ethnic minorities are influenced by varying degrees of skepticism related to trial participation, 2) potential minority participants often face multilevel barriers that preclude them from being offered an opportunity to participate in a clinical trial, 3) facilitators at both the institutional and participant level potentially encourage minority recruitment, and 4) variation between internal and external trial referral procedures may limit clinical trial opportunities for racial and ethnic minorities. CONCLUSIONS: Multilevel approaches are needed to address barriers and optimize facilitators within cancer centers to enhance minority recruitment for cancer clinical trials.
BACKGROUND: The study of disparities in minority recruitment to cancer clinical trials has focused primarily on inquiries among minority populations. Yet very little is known about the perceptions of individuals actively involved in minority recruitment to clinical trials within cancer centers. Therefore, the authors assessed the perspectives of cancer center clinical and research personnel on barriers and facilitators to minority recruitment. METHODS: In total, 91 qualitative interviews were conducted at 5 US cancer centers among 4 stakeholder groups: cancer center leaders, principal investigators, research staff, and referring clinicians. All interviews were recorded and transcribed. Qualitative analyses of response data was focused on identifying prominent themes related to barriers and facilitators to minority recruitment. RESULTS: The perspectives of the 4 stakeholder groups were largely overlapping with some variations based on their unique roles in minority recruitment. Four prominent themes were identified: 1) racial and ethnic minorities are influenced by varying degrees of skepticism related to trial participation, 2) potential minority participants often face multilevel barriers that preclude them from being offered an opportunity to participate in a clinical trial, 3) facilitators at both the institutional and participant level potentially encourage minority recruitment, and 4) variation between internal and external trial referral procedures may limit clinical trial opportunities for racial and ethnic minorities. CONCLUSIONS: Multilevel approaches are needed to address barriers and optimize facilitators within cancer centers to enhance minority recruitment for cancer clinical trials.
Authors: Anjali S Advani; Benjamin Atkeson; Carrie L Brown; Bercedis L Peterson; Laura Fish; Jeffrey L Johnson; Jon P Gockerman; Marc Gautier Journal: Cancer Date: 2003-03-15 Impact factor: 6.860
Authors: Lucile L Adams-Campbell; Chiledum Ahaghotu; Melvin Gaskins; Fitzroy W Dawkins; Duane Smoot; Octavius D Polk; Robert Gooding; Robert L DeWitty Journal: J Clin Oncol Date: 2004-02-15 Impact factor: 44.544
Authors: Raegan W Durant; Anna T Legedza; Edward R Marcantonio; Marcie B Freeman; Bruce E Landon Journal: J Natl Med Assoc Date: 2011-02 Impact factor: 1.798
Authors: Soumya J Niranjan; Raegan W Durant; Jennifer A Wenzel; Elise D Cook; Mona N Fouad; Selwyn M Vickers; Badrinath R Konety; Sarah B Rutland; Zachary R Simoni; Michelle Y Martin Journal: J Cancer Educ Date: 2019-02 Impact factor: 2.037
Authors: Monica Webb Hooper; Taghrid Asfar; Marina Unrod; Asha Dorsey; John B Correa; Karen O Brandon; Vani N Simmons; Michael A Antoni; Tulay Koru-Sengul; David J Lee; Thomas H Brandon Journal: Ethn Dis Date: 2019-01-17 Impact factor: 1.847
Authors: M Lizette Rangel; Natalia I Heredia; Belinda Reininger; Lorna McNeill; Maria E Fernandez Journal: J Cancer Educ Date: 2019-12 Impact factor: 2.037
Authors: Grace C Hillyer; Melissa Beauchemin; Dawn L Hershman; Moshe Kelsen; Frances L Brogan; Rossy Sandoval; Karen M Schmitt; Andria Reyes; Mary Beth Terry; Andrew B Lassman; Gary K Schwartz Journal: Clin Trials Date: 2020-02-03 Impact factor: 2.486
Authors: Nadine J Barrett; Kearston L Ingraham; Kenisha Bethea; Pao Hwa-Lin; Maritza Chirinos; Laura J Fish; Schenita Randolph; Ping Zhang; Peter Le; Demetrius Harvey; Ronald L Godbee; Steven R Patierno Journal: Adv Cancer Res Date: 2020-03-19 Impact factor: 6.242
Authors: Zachary R Simoni; Michelle Martin; Jennifer A Wenzel; Elise D Cook; Badrinath Konety; Selwyn M Vickers; Moon S Chen; Mona N Foaud; Raegan W Durant Journal: J Racial Ethn Health Disparities Date: 2016-11-08